207 related articles for article (PubMed ID: 31228739)
1. The design and application of a bacterial ghost vaccine to evaluate immune response and defense against avian pathogenic Escherichia coli O2:K1 serotype.
Hoseini Shahidi R; Hashemi Tabar G; Bassami MR; Jamshidi A; Dehghani H
Res Vet Sci; 2019 Aug; 125():153-161. PubMed ID: 31228739
[TBL] [Abstract][Full Text] [Related]
2. Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
Ebrahimi-Nik H; Bassami MR; Mohri M; Rad M; Khan MI
PLoS One; 2018; 13(3):e0194888. PubMed ID: 29566080
[TBL] [Abstract][Full Text] [Related]
3. Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80 serotype.
Soleymani S; Tavassoli A; Hashemi Tabar G; Kalidari GA; Dehghani H
Vet Res; 2020 Dec; 51(1):144. PubMed ID: 33298146
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Iss as a potential vaccine for avian colibacillosis.
Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK
Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546
[TBL] [Abstract][Full Text] [Related]
5. Use of a modified bacterial ghost lysis system for the construction of an inactivated avian pathogenic Escherichia coli vaccine candidate.
Hu J; Zuo J; Chen Z; Fu L; Lv X; Hu S; Shi X; Jing Y; Wang Y; Wang Z; Mi R; Huang Y; Liu D; Qi K; Han X
Vet Microbiol; 2019 Feb; 229():48-58. PubMed ID: 30642598
[TBL] [Abstract][Full Text] [Related]
6. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
Han Y; Liu Q; Willias S; Liang K; Li P; Cheng A; Kong Q
Vaccine; 2018 Feb; 36(8):1038-1046. PubMed ID: 29358057
[TBL] [Abstract][Full Text] [Related]
7. Generation of a safety enhanced Salmonella Gallinarum ghost using antibiotic resistance free plasmid and its potential as an effective inactivated vaccine candidate against fowl typhoid.
Jawale CV; Chaudhari AA; Lee JH
Vaccine; 2014 Feb; 32(9):1093-9. PubMed ID: 24406393
[TBL] [Abstract][Full Text] [Related]
8. A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli.
Melamed D; Leitner G; Heller ED
Avian Dis; 1991; 35(1):17-22. PubMed ID: 2029251
[TBL] [Abstract][Full Text] [Related]
9. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli.
Kariyawasam S; Wilkie BN; Gyles CL
Avian Dis; 2004; 48(2):287-99. PubMed ID: 15283416
[TBL] [Abstract][Full Text] [Related]
10. An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis.
Nagano T; Kitahara R; Nagai S
Microbiol Immunol; 2012 Sep; 56(9):605-12. PubMed ID: 22708916
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity in chickens with orally administered recombinant chicken-borne Lactobacillus saerimneri expressing FimA and OmpC antigen of O78 avian pathogenic Escherichia coli.
Ma ST; Ding GJ; Huang XW; Wang ZW; Wang L; Yu ML; Shi W; Jiang YP; Tang LJ; Xu YG; Li YJ
J Med Microbiol; 2018 Mar; 67(3):441-451. PubMed ID: 29458539
[TBL] [Abstract][Full Text] [Related]
12. A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli.
Van Goor A; Stromberg ZR; Mellata M
PLoS One; 2017; 12(8):e0183929. PubMed ID: 28837660
[TBL] [Abstract][Full Text] [Related]
13. Potential improvement of the immune response of chickens against E. coli vaccine by using two forms of chitosan nanoparticles.
Mohammed GM; ElZorkany HE; Farroh KY; Abd El-Aziz WR; Elshoky HA
Int J Biol Macromol; 2021 Jan; 167():395-404. PubMed ID: 33275976
[TBL] [Abstract][Full Text] [Related]
14. Immunization with outer membrane vesicles of avian pathogenic Escherichia coli O78 induces protective immunity in chickens.
Wang H; Liang K; Kong Q; Liu Q
Vet Microbiol; 2019 Sep; 236():108367. PubMed ID: 31500727
[TBL] [Abstract][Full Text] [Related]
15. Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens.
Chaudhari AA; Jawale CV; Kim SW; Lee JH
Vet Res; 2012 May; 43(1):44. PubMed ID: 22620989
[TBL] [Abstract][Full Text] [Related]
16. Advances in vaccination against avian pathogenic Escherichia coli respiratory disease: potentials and limitations.
Ghunaim H; Abu-Madi MA; Kariyawasam S
Vet Microbiol; 2014 Aug; 172(1-2):13-22. PubMed ID: 24878325
[TBL] [Abstract][Full Text] [Related]
17. Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys.
Sadeyen JR; Wu Z; Davies H; van Diemen PM; Milicic A; La Ragione RM; Kaiser P; Stevens MP; Dziva F
Vet Res; 2015 Jan; 46(1):5. PubMed ID: 25613193
[TBL] [Abstract][Full Text] [Related]
18. Avian pathogenic Escherichia coli ΔtonB mutants are safe and protective live-attenuated vaccine candidates.
Holden KM; Browning GF; Noormohammadi AH; Markham P; Marenda MS
Vet Microbiol; 2014 Oct; 173(3-4):289-98. PubMed ID: 25205199
[TBL] [Abstract][Full Text] [Related]
19. A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.
Han Y; Liu Q; Yi J; Liang K; Wei Y; Kong Q
Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28911037
[TBL] [Abstract][Full Text] [Related]
20. Construction of an attenuated Salmonella delivery system harboring genes encoding various virulence factors of avian pathogenic Escherichia coli and its potential as a candidate vaccine for chicken colibacillosis.
Chaudhari AA; Matsuda K; Lee JH
Avian Dis; 2013 Mar; 57(1):88-96. PubMed ID: 23678735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
